The leadership team at Theravance has experience in the finance, biochemistry, economics, and quantitative methods from various well-renowned institutions. Their previous experiences include working as the Chief Business Officer at Acorda Therapeutics, Inc., Board Member at Biotechnology Industry Organization, President and Chief Executive Officer at Tobira Therapeutics, Senior Vice President, Corporate Development at Nodality Inc., President, Oncology/Immunology/OTN/Global Marketing at Bristol-Myers Squibb, Princeton, New Jersey, and President, Bristol-Myers Squibb Oncology/Immunology/ Oncology Therapeutics Network (OTN); at Bristol-Myers Squibb.
View all